RPS6KA4 (ribosomal protein S6 kinase A4)

2006-10-01  

Identity

HGNC
LOCATION
11q13.1
LOCUSID
ALIAS
MSK2,RSK-B,S6K-alpha-4
FUSION GENES

Other Information

Locus ID:

NCBI: 8986
MIM: 603606
HGNC: 10433
Ensembl: ENSG00000162302

Variants:

dbSNP: 8986
ClinVar: 8986
TCGA: ENSG00000162302
COSMIC: RPS6KA4

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000162302ENST00000334205O75676
ENSG00000162302ENST00000528057E9PJN1
ENSG00000162302ENST00000528355E9PKU3
ENSG00000162302ENST00000530504A0A0A6YYC0

Expression (GTEx)

0
50
100
150

Pathways

PathwaySourceExternal ID
MAPK signaling pathwayKEGGko04010
MAPK signaling pathwayKEGGhsa04010
TNF signaling pathwayKEGGhsa04668
TNF signaling pathwayKEGGko04668
Developmental BiologyREACTOMER-HSA-1266738
Axon guidanceREACTOMER-HSA-422475
L1CAM interactionsREACTOMER-HSA-373760
Recycling pathway of L1REACTOMER-HSA-437239

Protein levels (Protein atlas)

Not detected
Low
Medium
High

References

Pubmed IDYearTitleCitations
368124802023Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states.3
372785622023Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival.1
374623382023Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses.0
368124802023Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states.3
372785622023Potentially functional genetic variants in RPS6KA4 and MAP2K5 in the MAPK signaling pathway predict HBV-related hepatocellular carcinoma survival.1
374623382023Comprehensive analysis of the RSK gene family in acute myeloid leukemia determines a prognostic signature for the prediction of clinical prognosis and treatment responses.0
344453612021Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction.1
344453612021Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction.1
289306102018RPS6KA4/MIR1237 and AURKC promoter regions are differentially methylated in Wilms' tumor.3
289306102018RPS6KA4/MIR1237 and AURKC promoter regions are differentially methylated in Wilms' tumor.3
261097212015Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.20
261097212015Screening of the Human Kinome Identifies MSK1/2-CREB1 as an Essential Pathway Mediating Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication during Primary Infection.20
247924382014Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes.11
247924382014Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes.11
236754622013Mitogen- and stress-activated protein kinases 1 and 2 are required for maximal trefoil factor 1 induction.8

Citation

Dessen P

RPS6KA4 (ribosomal protein S6 kinase A4)

Atlas Genet Cytogenet Oncol Haematol. 2006-10-01

Online version: http://atlasgeneticsoncology.org/gene/43479/rps6ka4